Evidence mapPaperPMID 41300434Full record

ArticleAntioxidants (Basel, Switzerland)2025

Vitamin B12 Protects the Exacerbated Ischemia-Reperfusion Injury-Induced Chronic Kidney Disease in Mice with Genetically Increased Elmo1.

Jiayi Zhou, Yuye Wang, John Hagaman, Qing Ma, J Charles Jennette, Meitong Chen, Xianwen Yi, Yukako Kayashima, Nobuyo Maeda-Smithies, Feng Li

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jiayi ZhouDepartment of Nutrition, Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0009-0009-7301-2698
Yuye WangDepartment of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0009-0009-7269-3575
John HagamanDepartment of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA.
Qing MaDepartment of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA.
J Charles JennetteDepartment of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA.
Meitong ChenDepartment of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA.
Xianwen YiDepartment of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0001-9320-2020
Yukako KayashimaDepartment of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA.
Nobuyo Maeda-SmithiesDepartment of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0002-2248-3299
Feng LiDepartment of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0002-6779-5077

Funding

Virology Research ProgramP30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · 1985 to 2025
$88.3M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · UNIV OF NORTH CAROLINA CHAPEL HILL · 2001 to 2025
$6.9M
MODELS FOR STUDYING THE GENETICS OF HYPERTENSIONR01HL049277 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · 1992 to 2025
$6.2M
Benefits of nicotinamide in placental development and in preeclamsiaR01HD101485 · UNIV OF NORTH CAROLINA CHAPEL HILL · 2025 to 2025
$410k
NCI NIH HHS P30 CA016086NHLBI NIH HHS R01 HL049277NICHD NIH HHS R01 HD101485NIEHS NIH HHS P30 ES010126NIH HHS 1R01HD101485-26NIH HHS 2R01HL049277-25
6 · The paper itself

Abstract

Ischemia-reperfusion injury (IRI) is a leading cause of acute kidney injury (AKI) and a major driver of progression to chronic kidney disease (CKD). Oxidative stress is recognized as a central mediator of this transition. Engulfment and Cell Motility 1 (ELMO1) regulates cytoskeletal remodeling and reactive oxygen species generation through Rac1 activation, but its contribution to CKD progression remains poorly defined. To investigate this, we established a unilateral renal IRI model in wild-type (WT) and

Indexed as

acute kidney injurychronic kidney diseaseELMO1Ischemia–reperfusion injuryoxidative stressvitamin B12

Identifiers

PMID41300434
PMCPMC12649674

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.